|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 309/15 | |
| C07D 263/57 | |||
| A61K 31/167 | |||
| A61K 31/423 | |||
| A61P 3/10 |
| (11) | Number of the document | 2326618 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09791510.2 |
| Date of filing the European patent application | 2009-08-13 | |
| (97) | Date of publication of the European application | 2011-06-01 |
| (45) | Date of publication and mention of the grant of the patent | 2014-10-15 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/053795 |
| Date | 2009-08-13 |
| (87) | Number | WO 2010/019830 |
| Date | 2010-02-18 |
| (30) | Number | Date | Country code |
| 88697 P | 2008-08-13 | US |
| (72) |
GOMEZ-GALENO, Jorge, E., US
HECKER, Scott, J., US
DANG, Qun, US
REDDY, Mali Venkat, US
SUN, Zhili, US
GROTE, Matthew, P., US
NGUYEN, Thanh Huu, US
LEMUS, Robert, Huerta, US
LI, Haiqing, US
|
| (73) |
Metabasis Therapeutics, Inc.,
11119 North Torrey Pines Road, La Jolla, CA 92037,
US
|
| (54) | GLUCAGON ANTAGONISTS |
| GLUCAGON ANTAGONISTS |